 |
Clinical Trial Begins For Innovative Drug-Eluting Stent With Unique Reservoir Technology (Medical News Today) |
A randomized clinical trial comparing the Conor Sirolimus-eluting Coronary Stent, a new cobalt chromium reservoir-base stent design, to the Taxus Liberte Paclitaxel-eluting Coronary Stent has begun according to Conor Medsystems, LLC and Cordis Corporation, the sponsors of the study.
More: continued here
This entry was posted on Monday, March 31st, 2008 and is filed under POLYMER. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a comment